[6-Thioguanine in the chemotherapy of leukemias].
D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents; D002648:Child; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D006801:Humans; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy*; D007939:Leukemia L1210 / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008875:Middle Aged; D009374:Neoplasms, Experimental / Q000188:drug therapy; D013866:Thioguanine / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use* / Q000633:toxicity
D000970:Antineoplastic Agents; D013866:Thioguanine
6-Tioguanin v khimioterapii leĭkozov.